A strategy for rational design of fully synthetic glycopeptide conjugate vaccines

Infection and Immunity

Volumn 65, Issue 12, 1997, Pages 4918-4925

  Chong, Pele ^a   Chan, Neville ^a   Kandil, Ali ^a   Tripet, Brian ^a   James, Olive ^a   Yang, Yan Ping ^a   Shi, Shan Pan ^a   Klein, Michel ^a  

^a Research Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPEPTIDE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE;

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; DRUG DESIGN; DRUG EFFICACY; DRUG SYNTHESIS; HAEMOPHILUS INFLUENZAE TYPE B; HELPER CELL; IMMUNOGENICITY; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; T LYMPHOCYTE;

EID: 0030776178     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.12.4918-4925.1997     Document Type: Article

References (34)

1. Alonso De Velasco, E., D. Merhus, S. Anderton, A. F. M. Verheul, E. F. Lizzio, R. Van der Zee, W. Van Eden, T. Huffman, and H. Snippe. 1995. Synthetic peptides representing T-cell epitopes act as carriers in pneumococcal polysaccharide conjugate vaccine. Infect. Immun. 63:961-968.
2. Anderson, P. 1978. Intrinsic tritium labeling of the capsular polysaccharide antigen of Haemophilus influenzae type b. J. Immunol. 120:866-870.
3. Anderson, P. W., M. E. Pichichero, E. C. Stein, S. Porcelli, R. F. Betts, D. M. Connuck, D. Korones, R. A. Insel, J. M. Zahradnik, and R. Eby. 1989. Effect of oligosaccharide chain length, exposed terminal group, and hapten loading on the antibody response of human adults and infants to vaccine consisting of Haemophilus influenzae type b capsular antigen uniterminally coupled to the diphtheria protein CRM197. J. Immunol. 142:2464-2468.
4. Calvo-Calle, J. M., G. A. de Oliverira, P. Clavijo, M. Maracic, J. P. Tam, Y. A. Lu, E. H. Nardin, R. S. Nussenzweig, and A. H. Cochrane. 1993. Immunogenicity of multiple antigen peptides containing B- and non-repeat T-cell epitopes of the circumsporozoite protein of Plasmodium falciparum, J. Immunol. 150:1403-1412.
5. 4a.Chong, P., et al. Unpublished results.
6. Chong, P., C. Sia, M. Syndor, and M. Klein. 1990. Identification of a potent synthetic HIV1 immunogen comprising gag-p24 tandem T- and B-cell epitopes. FEBS Lett. 264:231-234.
7. Chong, P., Y.-P. Yang, R. Fahim, P. McVerry, C. Sia, and M. Klein. 1993. Immunogenicity of overlapping synthetic peptides covering the entire sequence of Haemophilus influenzae type b outer membrane protein P2. Infect. Immun. 61:2653-2661.
8. Chong, P., O. James, Y.-P. Yang, C. Sia, B. Tripet, Y. Choi, and M. Klein. 1994. Mapping of the immunodominant B- and T-cell epitopes of the outer membrane protein P6 of H. Influenzae type b using overlapping synthetic peptides, p. 730-731. In R. S. Hodges and J. A. Smith (ed.), Peptides: chemistry, structure and biology. Escom, Leiden, The Netherlands.
9. Chong, P., Y.-P. Yang, D. Persaud, M. Haer, B. Tripet, E. Tarn, C. Sia, and M. Klein. 1995. Immunogenicity of synthetic peptides of Haemophilus influenzae type b outer membrane protein P1, Infect. Immun. 63:3751-3758.
10. Cox, J. H., J. Ivanyi, D. B. Young, J. R. Lamb, A. D. Syred, and M. J. Francis. 1988. Orientation of epitopes influences the immunogenicity of synthetic peptide dimers. Eur. J. Immunol. 18:2015-2019.
11. Granoff, D. M., E. L. Anderson, M. T. Osterholm, S. J. Holmes, J. E. McHugh, R. B. Belshe, F. Medley, and T. V. Murphy. 1992. Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants. J. Pediatr. 121:187-194.
12. Granoff, D. M., S. J. Holmes, R. B. Belshe, M. T. Osterholm, J. E. McHugh, and E. L. Anderson. 1994. Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants. JAMA 272:1116-1121.
13. Greenberg, D. P., J. M. Lieberman, S. M. Marcy, V. K. Wong, S. Partridge, S.-J. Chang, C. Y. Chiu, and J. I. Ward. 1995. Enhanced antibody responses in infants given different sequences of heterogeneous Haemophilus influenzae type b conjugate vaccine. J. Pediatr. 126:206-211.
14. Jennings, H. J., and C. Lugowski. 1981. Immunogenicity of groups A, B, and C meningococcal polysaccharide-tetanus toxoid conjugates. J. Immunol. 127: 1011-1018.
15. Kandil, A. A., N. Chan, P. Chong, and M. H. Klein. 1992. Synthesis of fragment of the capsular polysaccharide of Haemophilus influenzae type h on soluble polymer support. Synlett 7:555-557.
16. Kandil, A. A., N. Chan, M. H. Klein, and P. Chong. 1997. Chemical synthesis of Haemophilus influenzae glycopeptide conjugates. Glycoconjugate J. 14:13-17.
17. Kyd, J. M., M. L. Dunkley, and A. W. Cripps. 1995. Enhanced respiratory clearance of nontypeable Haemophilus infiuenzae following mucosal immunization with P6 in a rat model. Infect. Immun. 63:2931-2940.
18. Levely, M. E., M. A. Mitchell, and J. A. Nicholas. 1990. Synthetic immunogens constructed from T-cell and B-cell stimulating peptides (T:B chimeras): preferential stimulation of unique T- and B-cell specificities is influenced by immunogen configuration. Cell Immunol. 125:65-72.
19. Lieberman, J. M., D. P. Greenberg, V. K. Wong, S. Partridge, S.-J. Chang, C. Y. Chiu, and J. I. Ward. 1995. Effect of neonatal immunization with diphtheria and tetanus toxoids on antibody responses to Haemophilus influenzae type b conjugate vaccines. J. Pediatr. 126:198-205.
20. Mouritsen, S., M. Meldal, I. Christiansen-Brams, H. Elsner, and O. Werdelin. 1994. Attachment of oligosaccharides to peptide antigen profoundly affects binding to major histocompatibility complex class II molecules and peptide immunogenicity. Eur. J. Immunol. 24:1066-1072.
21. Munson, R. S., Jr., J. L. Shenep, S. J. Barenkamp, and D. M. Granoff. 1983. Purification and comparison of outer membrane protein P2 from Haemophilus influenzae type b isolates. J. Clin. Invest. 72:677-684.
22. Nelson, M. B., R. S. Munson, Jr., M. A. Apicella, D. J. Sikkema, J. P. Molleston, and T. F. Murphy. 1991. Molecular conservation of the P6 outer membrane protein among strains of Haemophilus influenzae: analysis of antigenic determinants, gene sequences, and restriction fragment length polymorphisms. Infect. Immun. 59:2658-2663.
23. Panezutti, H., O. James, E. J. Hansen, Y. Choi, R. E. Harkness, M. H. Klein, and P. Chong. 1993. Identification of surface-exposed B-cell epitopes recognized by Haemophilus influenzae type b P1-specific monoclonal antibodies. Infect. Immun. 61:1867-1872.
24. Partidos, C., C. Stanley, and M. Steward. 1992. The effect of orientation of epitopes on the immunogenicity of chimeric peptides representing measles virus protein sequences. Mol. Immunol. 29:651-657.
25. Peeters, C. C. A. M., D. Evenberg, P. Hoogerhout, H. Käyhty, L. Saarinen, C. A. A. van Boeckel, G. A. van der Marel, J. H. van Boom, and J. T. Poolman. 1992. Synthetic trimer and tetramer of 3-β-D-ribose-(1-1)-D-ribitol-5-phosphate conjugated to protein induce antibody responses to Hae- mophilus influenzae type b capsular polysaccharide in mice and monkeys. Infect. Immun. 60:1826-1833.
26. Redhead, K., J. Watkins, A. Barnard, and K. H. G. Mills. 1993. Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity. Infect. Immun. 61:3190-3198.
27. Riddles, P. W., R. L. Blackeley, and B. Zerner. 1983. Reassessment of Ellman's reagent. Methods Enzymol. 91:49-60.
28. Sia, C., P. Chong, B. Caplan, T. Matthews, R. Oomen, J. Caterini, D. Bolognesi, and M. Klein. 1991. Structure and immunogenicity of synthetic HIV tandem epitopes, p. 105-110. In M. Girard and L. Valette (ed.), Retroviruses of human A.I.D.S. and related animal diseases. 6e Colloque des Cent Gardes. Fondation Marcel Merieux Publication, Lyon, France.
29. Siber, G. R., R. Anderson, M. Habsfy, and R. K. Gupta. 1995. Development of a guinea pig model to assess immunogenicity of Haemophilus influenzae type b capsular polysaccharide conjugate vaccines. Vaccine 13:525-531.
30. Smith, D. J., M. A. Taubman, C. F. Holmberg, J. Eastcott, W. F. King, and P. Ali-Salaam. 1993. Antigenicity and immunogenicity of a synthetic peptide derived from a glucan-binding domain of mutans streptococcal glucosyl- transferase. Infect. Immun. 61:2899-2905.
31. Tam, J. P. 1996. Recent advances in multiple antigen peptides. J. Immunol. Methods 196:17-32.
32. Toyokuni, T., B. Dean, S. Cai, D. Boivin, S. Hakomori, and A. K. Singhai. 1994. Synthetic vaccines: synthesis of a dimeric Tn antigen-lipopeptide conjugate that elicits immune responses against Tn-expressing glycoproteins. J. Am. Chem. Soc. 116:395-396.
33. Wiesmuller, K.-L., W. Bessler, and G. Jung, G. 1983. Synthesis of the mitogenic S-[2,3-bis(palmitoyloxy)propyl]-N-palmitoylpentapeptide from Esche- richia coli lipoprotein. Hoppe-Seyler's Z. Physiol. Chem. 364:593-606.
34. Yang, Y.-P., R. S. Munson, Jr., S. Grass, P. Chong, R. E. Harkness, L. Gisonni, O. James, and M. H. Klein. 1997. Purification of a recombinant non-fatty acylated form of the P6 protein from H. influenzae and comparison with its native counterpart. Vaccine 15:976-987.